Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alteogen enters into an Exclusive License Agreement to Develop and Commercialize Subcutaneous ENHERTU® Enabled by Alteogen's Hybrozyme™ Technology 2024-11-11 08:07
International companies to host live webcasts at Deutsche Bank's June 9th and 10th Depositary Receipts Virtual Investor Conference 2016-06-06 21:00
Daiichi Sankyo to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on Thursday, June 9th, 2016 2016-06-06 20:30
Daiichi Sankyo to Expand Its Collaborative Drug Discovery Program to Germany, Switzerland and Austria 2013-07-29 12:00
Daiichi Sankyo and Lilly Announce TRILOGY ACS Results Regarding Effient(R) (Prasugrel) in Acute Coronary Syndrome UA/NSTEMI Patients to be Managed Medically without an Artery-Opening Procedure 2012-08-27 08:07
1